ORLANDONI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 3.112
EU - Europa 1.319
AS - Asia 1.275
SA - Sud America 304
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 3
Totale 6.149
Nazione #
US - Stati Uniti d'America 3.031
SG - Singapore 461
UA - Ucraina 229
VN - Vietnam 228
CN - Cina 226
BR - Brasile 223
RU - Federazione Russa 213
IT - Italia 183
SE - Svezia 128
DE - Germania 125
IE - Irlanda 115
TR - Turchia 105
HK - Hong Kong 91
DK - Danimarca 87
FR - Francia 84
FI - Finlandia 73
KR - Corea 48
GB - Regno Unito 41
CI - Costa d'Avorio 38
AR - Argentina 26
BD - Bangladesh 24
CA - Canada 24
MX - Messico 21
CO - Colombia 16
IN - India 16
ZA - Sudafrica 15
JP - Giappone 12
EC - Ecuador 11
IQ - Iraq 10
MA - Marocco 10
ID - Indonesia 7
NL - Olanda 7
UZ - Uzbekistan 7
VE - Venezuela 7
CR - Costa Rica 6
ES - Italia 6
PK - Pakistan 6
PY - Paraguay 6
BE - Belgio 5
CL - Cile 5
HN - Honduras 5
MY - Malesia 5
PL - Polonia 5
PR - Porto Rico 5
OM - Oman 4
PE - Perù 4
SA - Arabia Saudita 4
SV - El Salvador 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
AT - Austria 3
DZ - Algeria 3
GT - Guatemala 3
JO - Giordania 3
KZ - Kazakistan 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
EG - Egitto 2
LT - Lituania 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GP - Guadalupe 1
GY - Guiana 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SX - ???statistics.table.value.countryCode.SX??? 1
TO - Tonga 1
WS - Samoa 1
Totale 6.094
Città #
Ashburn 541
Singapore 298
Chandler 225
Jacksonville 225
Fairfield 191
Dallas 172
San Jose 158
Dublin 115
Boardman 97
Wilmington 96
Hong Kong 86
Council Bluffs 84
Seattle 84
Woodbridge 82
Ho Chi Minh City 78
Houston 71
New York 71
Beijing 64
Moscow 58
Hanoi 56
Princeton 51
Ann Arbor 50
Cambridge 50
Lawrence 45
San Mateo 45
Turin 45
Lauterbourg 39
Abidjan 38
Los Angeles 34
The Dalles 33
Hefei 32
Buffalo 25
São Paulo 25
Munich 21
Santa Clara 21
Milan 19
Orem 19
Turku 19
Phoenix 17
San Diego 17
Des Moines 15
Chicago 12
Johannesburg 11
Da Nang 10
London 10
Shanghai 10
Tokyo 10
Denver 9
Helsinki 9
Brooklyn 8
Centro 8
Izmir 8
Montreal 8
Atlanta 7
Falls Church 7
Guangzhou 7
Naples 7
Nuremberg 7
Tashkent 7
Brasília 6
Chennai 6
Haiphong 6
Manchester 6
Mexico City 6
Miano 6
Rio de Janeiro 6
Rome 6
Wuhan 6
Brussels 5
Can Tho 5
Columbus 5
Guayaquil 5
Poplar 5
Stockholm 5
Warsaw 5
Amsterdam 4
Baghdad 4
Bogotá 4
Boston 4
Charlotte 4
Chelsea 4
Guarulhos 4
Hangzhou 4
Istanbul 4
Montevideo 4
Norwalk 4
Paris 4
San Antonio 4
Wuxi 4
Bauru 3
Biên Hòa 3
Bắc Ninh 3
Campinas 3
Campobasso 3
Caracas 3
Curitiba 3
Detroit 3
Dhaka 3
Indaiatuba 3
Jakarta 3
Totale 3.845
Nome #
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 275
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 207
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 191
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 170
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 163
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 161
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 157
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 155
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 154
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 151
EFFECT OF PLATELET RICH PLASMA CONCENTRATION ON SKELETAL MUSCLE REGENERATION: AN EXPERIMENTAL STUDY 149
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 146
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 141
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 141
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 140
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 138
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 138
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 134
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 132
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 131
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 131
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 131
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 130
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 129
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 127
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 126
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 126
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 124
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 123
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 123
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 122
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 122
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 121
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 120
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 118
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 112
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 111
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 109
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 109
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 104
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 103
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 101
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 100
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 98
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 91
Devices for minimally invasive liver parenchyma transection: the SICE (Italian Society of Endoscopic Surgery) Italian and International survey 64
Totale 6.149
Categoria #
all - tutte 27.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022265 0 0 0 4 6 38 21 13 25 63 15 80
2022/2023644 65 80 53 43 49 75 0 28 158 3 76 14
2023/2024308 63 9 15 50 55 76 3 3 0 1 5 28
2024/2025793 109 52 45 36 40 54 72 40 145 35 91 74
2025/20262.231 140 246 181 235 219 144 361 233 208 167 20 77
2026/2027383 66 69 99 149 0 0 0 0 0 0 0 0
Totale 6.149